IPO - Adagio Medical Holdings, Inc.

Form Type: CORRESP

Filing Date: 2025-02-05

Corporate Action: Ipo

Type: New

Accession Number: 000110465925009496

Filing Summary: Adagio Medical Holdings, Inc. filed a request for acceleration of the effective date of their pre-effective amendment to Registration Statement on Form S-1. The request is to have the registration effective by 4:00 p.m. Eastern Time on February 7, 2025, or as soon as practicable thereafter. This amendment pertains to the registration statement which was filed under File No. 333-284263, related to their proposed initial public offering (IPO). The request was addressed to the U.S. Securities and Exchange Commission, specifically to Nicholas O’Leary, and the communication was facilitated through Reed Smith LLP, with contact details provided for any questions.

Document Link: View Document

Form Type: S-1/A

Filing Date: 2025-02-04

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925009185

Filing Summary: On February 4, 2025, Adagio Medical Holdings, Inc. filed Pre-Effective Amendment No. 1 to their registration statement on Form S-1 with the SEC. This amendment updates the Executive Compensation section based on compensation details for the fiscal year ended December 31, 2024. The filing addresses the registration of up to 73,333 shares of Common Stock, 31,145,319 shares issuable upon conversion of notes, and 600,000 shares issuable upon exercise of warrants. It highlights that no additional securities are being registered, emphasizing the significant number of shares potentially being sold, which may influence the trading price of their Common Stock listed on Nasdaq under the symbol "ADGM". The document indicates the company is an emerging growth company and outlines various forward-looking statements regarding business operations, risks, and market competition. There are also disclosures about prior registration statements leading up to this amendment, including business combinations and changes in corporate structure.

Document Link: View Document

Form Type: S-1/A

Filing Date: 2025-02-04

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925009194

Filing Summary: Adagio Medical Holdings, Inc. filed a Pre-Effective Amendment No. 1 to its Form S-1 registration statement on February 4, 2025. The filing updates the Executive Compensation section to reflect compensation paid in the fiscal year ended December 31, 2024. This amendment does not register additional securities under the existing registration statement but rather serves to update the details of the offering that went effective on September 19, 2024. Adagio aims to offer a total of 67,963,695 shares of common stock, including 12,146,988 shares, 9,098,727 shares issuable on warrant exercise, and 46,717,980 shares from convertible notes among others. The common stock is listed on The Nasdaq Capital Market under the symbol 'ADGM'. The filing also includes disclosures regarding the potential market volatility associated with these securities and the implications of the Business Combination with ARYA Sciences Acquisition Corp IV.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-14

Corporate Action: Ipo

Type: New

Accession Number: 000110465925003193

Filing Summary: Adagio Medical Holdings, Inc. has filed an S-1 registration statement in connection with its initial public offering (IPO). The document outlines the pricing of the shares to be offered, financials, use of proceeds, and details regarding the company’s operations. The company aims to capitalize on market opportunities in its sector and enhance its growth potential through this public offering. The anticipated use of proceeds includes investing in product development and expanding operational capacities, which is critical for its strategic growth plans. Additionally, the document provides insights into risk factors associated with the IPO, regulatory environments, competitive analysis, and potential market challenges that the company may face as it transitions to a public entity.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-14

Corporate Action: Ipo

Type: New

Accession Number: 000110465925003291

Filing Summary: Adagio Medical Holdings, Inc. has filed an S-1 registration statement with the SEC, marking a significant step toward its initial public offering (IPO). The document outlines the company's plans to offer shares to the public and details the financial information, use of proceeds, and business strategy. Key points include the potential market impact, the financial health of the company, projected growth, and risks associated with the investment. Additionally, it highlights previous convertible note offerings and other financing strategies aimed at supporting its future growth.

Document Link: View Document